ATE232850T1 - Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren - Google Patents

Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren

Info

Publication number
ATE232850T1
ATE232850T1 AT97923065T AT97923065T ATE232850T1 AT E232850 T1 ATE232850 T1 AT E232850T1 AT 97923065 T AT97923065 T AT 97923065T AT 97923065 T AT97923065 T AT 97923065T AT E232850 T1 ATE232850 T1 AT E232850T1
Authority
AT
Austria
Prior art keywords
dopamine
modulators
receptors
tetrahydroisoquinoline derivatives
tetrahydroisoquinoline
Prior art date
Application number
AT97923065T
Other languages
English (en)
Inventor
Geoffrey Stemp
Amanda Johns
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609888.4A external-priority patent/GB9609888D0/en
Priority claimed from GBGB9617189.7A external-priority patent/GB9617189D0/en
Priority claimed from GBGB9704490.3A external-priority patent/GB9704490D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE232850T1 publication Critical patent/ATE232850T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT97923065T 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren ATE232850T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9609888.4A GB9609888D0 (en) 1996-05-11 1996-05-11 Compounds
GBGB9617189.7A GB9617189D0 (en) 1996-08-16 1996-08-16 Compounds
GBGB9704490.3A GB9704490D0 (en) 1997-03-05 1997-03-05 Compounds
PCT/EP1997/002434 WO1997043262A1 (en) 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors

Publications (1)

Publication Number Publication Date
ATE232850T1 true ATE232850T1 (de) 2003-03-15

Family

ID=27268278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923065T ATE232850T1 (de) 1996-05-11 1997-05-06 Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren

Country Status (18)

Country Link
US (1) US6046210A (de)
EP (1) EP0917530B1 (de)
JP (1) JP2000510137A (de)
KR (1) KR20000010905A (de)
AR (1) AR007077A1 (de)
AT (1) ATE232850T1 (de)
AU (1) AU2897497A (de)
BR (1) BR9709220A (de)
CA (1) CA2253927A1 (de)
CZ (1) CZ363298A3 (de)
DE (1) DE69719191T2 (de)
ES (1) ES2191838T3 (de)
IL (1) IL126747A0 (de)
NO (1) NO985242L (de)
NZ (1) NZ332477A (de)
PL (1) PL329803A1 (de)
TR (1) TR199802284T2 (de)
WO (1) WO1997043262A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2263284A1 (en) * 1996-08-14 1998-02-19 Smithkline Beecham P.L.C. Tetrahydroisoquinoline derivatives and their pharmaceutical use
GB9708694D0 (en) * 1997-04-30 1997-06-18 Smithkline Beecham Plc Compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
BR9809591A (pt) * 1997-05-03 2001-09-11 Smithkline Beecham Plc Derivados de tetraidoisoquinolina como moduladores de receptores de dopamina d3
GB9709303D0 (en) * 1997-05-09 1997-06-25 Smithkline Beecham Plc Compounds
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
GB9812522D0 (en) * 1998-06-10 1998-08-05 Smithkline Beecham Plc Compounds
GB9821978D0 (en) 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
WO2000021951A1 (en) * 1998-10-08 2000-04-20 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
GB9821977D0 (en) * 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
TWI274750B (en) 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
AU2003245773A1 (en) 2002-02-15 2003-09-04 Glaxo Group Limited Vanilloid receptor modulators
AR040126A1 (es) 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
WO2005048810A2 (en) * 2003-07-31 2005-06-02 Washington University In St. Louis Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
US7659400B2 (en) * 2003-07-31 2010-02-09 Washington University Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
KR20070047763A (ko) * 2004-07-20 2007-05-07 시에나 바이오테크 에스.피.에이. 알파7 니코틴성 아세틸콜린 수용체의 조절제 및 그의치료적 용도
US20060235028A1 (en) * 2005-04-14 2006-10-19 Li James J Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
TW200901974A (en) 2007-01-16 2009-01-16 Wyeth Corp Compounds, compositions, and methods of making and using them
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
CN102264733B (zh) 2008-10-10 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 新型多巴胺d3受体配体,其制备方法及其医药用途
WO2016034673A1 (en) 2014-09-03 2016-03-10 Ctxt Pty Ltd Tetrahydroisoquinoline derived prmt5-inhibitors
EP3189048B1 (de) 2014-09-03 2021-03-17 Ctxt Pty Ltd Vom aminoindan, aminotetrahydronaphthalen und aminobenzocyclobutan abgeleitete prmt5-inhibitoren
GB201415573D0 (en) 2014-09-03 2014-10-15 Cancer Therapeutics Crc Pty Ltd Compounds
GB201604020D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604030D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604031D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604022D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604027D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
GB201604029D0 (en) 2016-03-09 2016-04-20 Ctxt Pty Ltd Compounds
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物
CA3089498A1 (en) 2018-01-26 2019-08-01 Shionogi & Co., Ltd. Condensed ring compounds having dopamine d3 receptor antagonistic effect

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen

Also Published As

Publication number Publication date
NO985242L (no) 1998-12-09
PL329803A1 (en) 1999-04-12
CZ363298A3 (cs) 1999-06-16
EP0917530B1 (de) 2003-02-19
DE69719191D1 (de) 2003-03-27
JP2000510137A (ja) 2000-08-08
NO985242D0 (no) 1998-11-10
TR199802284T2 (xx) 2000-05-22
BR9709220A (pt) 1999-08-10
AU2897497A (en) 1997-12-05
NZ332477A (en) 2000-07-28
DE69719191T2 (de) 2003-11-27
CA2253927A1 (en) 1997-11-20
IL126747A0 (en) 1999-08-17
US6046210A (en) 2000-04-04
AR007077A1 (es) 1999-10-13
WO1997043262A1 (en) 1997-11-20
ES2191838T3 (es) 2003-09-16
KR20000010905A (ko) 2000-02-25
EP0917530A1 (de) 1999-05-26

Similar Documents

Publication Publication Date Title
DE69719191D1 (de) Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
NO995338D0 (no) Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer
DE69813616D1 (de) Cyclohexencarboxylate als inhibitoren der neuraminidase
DE69712331D1 (de) Pyrimidin-4-on derivate als pestizidesmittel
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
DE69401823D1 (de) Indolin derivate als 5ht2c antagonisten
DE69723446D1 (de) Oxindole derivate
PT1001934E (pt) Compostos de indole como inibidores de cox-2
DE69841138D1 (de) Imidazolderivate als mdr-modulatoren
PT1036072E (pt) Antagonistas de receptores de trombina
DE69714265D1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE69819903D1 (de) Bizyklische verbindungen als liganden der 5-ht1 rezeptoren
ATE240943T1 (de) Isochinolin derivate als urokinase inhibitoren
PT696194E (pt) Utilizacao de derivados de indole como antagonistas de 5ht1
ATE254621T1 (de) Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten
DE69703242D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69803689D1 (de) 8-azabicyclo(3.2.1)0ctan-3-methanaminderivate als liganden der dopamin-rezeptoren d2 und d3 und der serotonin-rezeptoren 5ht1a und 5ht2
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
EE9800281A (et) Kondenseeritud imidasoolderivaadid multiravimiresistentsi moduleerijatena
DE69717449D1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten
DE69903627D1 (de) Tetrahydroisochinolinderivate als modulatoren von dopamin d3 rezeptoren
ATE208764T1 (de) Isazole derivate als fibrinogen-rezeptor- antagonisten
ATE305925T1 (de) Positive modulatoren von nicotinrezeptor- agonisten
DE69710305D1 (de) Derivate von 4-Vinyl-4'-alpha-hydroxyethyl-biphenyl

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties